Our Linked In site discusses the changing use of DNA microarrays by labs. Only a small percentage of labs will continue to purchase these systems.
What do vendors do when customers using a product don't plan to use it much longer? In the case of DNA Microarrays it means vendors must adapt, sell consumables, and take advantage of the installed base of market new products.
While labs are getting use out of DNA microarrays, in the future they plan to make changes. Kalorama's most recent survey of labs 'DNA Micorarray Trends' found that labs using DNA Microarray for gene expresson profiling, SNP genotyping and other tasks will for the most part keep their existing systems and not upgrade. When they do get a budget for purchasing in many cases tasks performed by the microarray system will be shifted to some of the powerful next generation sequencing products.
Our survey found that only about 10% of labs have plans to replace their microarray system and that it was more common for upgraders to desire a sequencer rather than a microarray system. Vendors have caught on. Companies have been offering trade-ins or also making hybrid systems capable of both running microarrays and sequencing.
In this, our analyst Justin Saeks sees a slight advantage for Illumina. See our Linked In site for more of the insights discovered in this DNA Microarray lab survey conducted by Kalorama Information analyst Justin Saeks.
